OTCMKTS:BMCS BioTech Medics (BMCS) Stock Price, News & Analysis $0.01 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About BioTech Medics Stock (OTCMKTS:BMCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioTech Medics alerts:Sign Up Key Stats Today's Range$0.0108▼$0.010850-Day Range$0.0050▼$0.014052-Week Range$0.00▼$0.02VolumeN/AAverage Volume20,912 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida. Read More Receive BMCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioTech Medics and its competitors with MarketBeat's FREE daily newsletter. Email Address BMCS Stock News HeadlinesMedicamen Biotech Ltd (MEBI)October 30, 2024 | investing.comBioTech Medics Inc: BioTech Medics-OTC CEO Interview and the Company Launches Its YouTube ChannelAugust 12, 2024 | finanznachrichten.deTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...August 9 at 2:00 AM | InvestorPlace (Ad)BioTech Medics Inc: Bmcs Introduces You to Its Commodity Vault Website and Commodity Vault AppJuly 29, 2024 | finanznachrichten.deBMCS Sumcoin Index Fund Inc (BMCS)January 3, 2024 | investing.comBioTech Medics Inc.: BioTech Medics Continues to Execute Its Calcium Business PlansNovember 20, 2023 | finanznachrichten.deBioTech Medics Continues to Execute Its Calcium Business PlansNovember 20, 2023 | finance.yahoo.comBiotech Medics has Acquired Organic Calcium AssetsOctober 2, 2023 | finance.yahoo.comSee More Headlines BMCS Stock Analysis - Frequently Asked Questions How have BMCS shares performed this year? BioTech Medics' stock was trading at $0.0165 at the start of the year. Since then, BMCS shares have decreased by 34.5% and is now trading at $0.0108. How do I buy shares of BioTech Medics? Shares of BMCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioTech Medics own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioTech Medics investors own include Artificial Intelligence Technology Solutions (AITX), Elys BMG Group (ELYS), Foresight Autonomous Holdings Ltd. American Depositary Shares (FRSX), GNCC Capital (GNCP), GBT Technologies (GTCH), Sorrento Therapeutics (SRNE) and Blink Charging (BLNK). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:BMCS CIK1384066 Webbiotecmedics.com Phone(800) 988-3782FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:BMCS) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioTech Medics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioTech Medics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.